Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $580 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a $580 price target.

April 04, 2024 | 2:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Elevance Health and maintained a $580 price target.
The reiteration of an Overweight rating and maintenance of a high price target by a reputable analyst suggests a positive outlook for Elevance Health's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100